Evidence map›Paper›PMID 42194039›Full record

ArticleBiomolecules2026

Recharacterization of EmAGA, a Potential Candidate for Novel ALL Therapeutics.

Qiange Lin, Yuxin Zhang, Junyou Lin, Yilin Ye, Xin Qian, Xinrong Lu, Shaoxian Lyu, Xinliu Geng, Li Chen, Guiqin Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qiange LinSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yuxin ZhangSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Junyou LinSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yilin YeSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xin QianSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xinrong LuKey Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Shaoxian LyuKey Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Xinliu GengKey Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Li ChenKey Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
Guiqin SunSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Funding

the Cooperation Project of Pingyang Traditional Chinese Medicine Hospital 2025-HT-669
6 · The paper itself

Abstract

Aspartylglucosaminidase (AGA) is an amidohydrolase that can hydrolyze the amide bond between N-acetylglucosamine (GlcNAc) and asparagine (Asn), producing N-acetylglucosamine and aspartic acid (Asp). AGA is distributed in both eukaryotes and prokaryotes. In this study, we identified the sequence of AGA in

Indexed as

AspartylglucosylaminaseBacterial ProteinsFlavobacteriaceaePrecursor Cell Lymphoblastic Leukemia-LymphomaEscherichia coliHumansHydrolysisMolecular Dynamics SimulationMutationProtein ConformationSequence HomologySubstrate SpecificityWhole Genome SequencingAspartylglucosylaminaseBacterial Proteinsacute lymphoblastic leukemiaasparagineaspartylglucosaminidaseautoproteolysisglutaminemolecular dynamics simulation

Identifiers

PMID42194039
PMCPMC13204146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.